Veterinary Medicines

Bryophyllum comp. A PlantaVet

Authorised
  • ARGENTUM METALLICUM DIL. D5
  • KALANCHOE DAIGREMONTIANA/PINNATA E FOLIIS FERM 33B DIL. D3 (HAB, VS. 33B)
Download as PDF

Product identification

Medicine name:
Bryophyllum comp. A PlantaVet
Active substance:
  • ARGENTUM METALLICUM DIL. D5
  • KALANCHOE DAIGREMONTIANA/PINNATA E FOLIIS FERM 33B DIL. D3 (HAB, VS. 33B)
Target species:
  • Horse
  • Cattle
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • ARGENTUM METALLICUM DIL. D5
    1.00
    gram(s)
    /
    10.00
    millilitre(s)
  • KALANCHOE DAIGREMONTIANA/PINNATA E FOLIIS FERM 33B DIL. D3 (HAB, VS. 33B)
    1.00
    gram(s)
    /
    10.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Milk
        0
        day
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Horse
      • Milk
        0
        day
      • Meat and offal
        0
        day
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Saluvet GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Wala-Heilmittel GmbH
  • Wala-Heilmittel GmbH
Responsible authority:
  • BVL
Authorisation number:
  • 6442562.00.00
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."